SCHEMBL7228041

SCHEMBL7228041

Cc1ccnc(Nc2ncc(-c3ccccc3)s2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDR P35968 16/20 1.00
CHEK1 O14757 1/20 0.59
ABL1 P00519 1/20 0.58
LCK P06239 1/20 0.58
CSF1R P07333 1/20 0.58
PDGFRB P09619 1/20 0.58
MAP2K2 P36507 1/20 0.58
CDK7 P50613 1/20 0.58
MEN1 O00255 1/20 0.57
NPC1 O15118 1/20 0.57
CASP3 P42574 1/20 0.57
RAB9A P51151 1/20 0.57
KMT2A Q03164 1/20 0.57
SENP8 Q96LD8 1/20 0.57
SENP7 Q9BQF6 1/20 0.57
SENP6 Q9GZR1 1/20 0.57
JAK2 O60674 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13524909 0.89 KDR (0.80) KDRCHEK1MEN1NPC1CASP3
SCHEMBL14240414 0.86 KDR (0.76) KDRCHEK1ABL1LCKCSF1R
SCHEMBL6180047 0.84 KDR (0.77) KDRABL1LCKCSF1RPDGFRB
SCHEMBL7237187 0.82 KDR (0.73) KDRCHEK1ABL1LCKCSF1R
SCHEMBL6179920 0.81 KDR (1.00) KDRABL1LCKCSF1RPDGFRB
SCHEMBL7242068 0.80 KDR (0.68) KDRCHEK1ABL1LCKCSF1R
SCHEMBL7227864 0.80 KDR (1.00) KDRABL1LCKCSF1RPDGFRB
SCHEMBL7234816 0.80 KDR (0.66) KDRCHEK1ABL1LCKCSF1R
SCHEMBL6179560 0.79 KDR (0.78) KDRLCKMEN1NPC1RAB9A
SCHEMBL6328806 0.78 KDR (0.71) KDRABL1LCKCSF1RPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6586424-B2 Anticancer agents; anticholesterol agents MERCK & CO., INC. 2003-07-01 US disclosed
US-6586423-B2 2-(Pyridin-2-ylamino)-thiazole-5-carbonitrile derivatives; angiogenesis inhibitors; antitumor and anticarcinogenic agents; atherosclerosis, macular degeneration, diabetic retinopathy MERCK & CO., INC. 2003-07-01 US disclosed